Remove Labelling Remove Packaging Remove Webinar
article thumbnail

What are the Top Pharma Podcasts in 2025?

Pharma Marketing Network

Many leaders now prefer podcasts over webinars or whitepapers for staying informed. FDA Frontlines” A reliable resource for regulatory professionals, FDA Frontlines keeps tabs on advisory committee decisions, label expansions, and safety communications. Another reason for their rise is the growing need for real-time updates.

article thumbnail

New IFPMA and EFPIA guidance on use of social media by the pharmaceutical industry

pharmaphorum

WebinarsWebinars, whether live streamed or on-demand, can be used for communication with HCPs, HCOs, and POs. A company is responsible for the content of webinars and should take reasonable steps to ensure the audience is targeted and well defined.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

DSCSA Postponement And What It Means For Independent Pharmacies

DiversifyRx

Join our next Awesome Webinar Series with guest legal guru JD from Real Value Rx to answer any questions you have about the DSCSA delay. Small Dispensers and the 6/12/2024 FDA Announcement Concerning DSCSA This week’s article on the recent DSCSA postponement comes from PRS Pharmacy Services. The original article can be found HERE.

article thumbnail

Lorundrostat Shows Clinically Meaningful Outcomes in Patients With CKD and Hypertension

Pharmacy Times

Along with the successful pivotal trials, Launch-HTN and Advance-HTN, and the ongoing open-label extension trial, these results comprise the core package for our planned NDA submission.” Explore-CKD established that lorundrostat 25 mg once daily has a favorable clinical profile for this patient population.

article thumbnail

FDA Approves Tablet Formulation of Zanubrutinib for All Indications

Pharmacy Times

1,2 Image Credit: © stockdevil - stock.adobe.com Results from 2 single-dose, open-label, randomized phase 1 crossover studies of healthy adults served as the basis for this approval. Package insert. These trials were designed to establish bioequivalence between zanubrutinib capsules and zanubrutinib tablets. News Release.

FDA 73
article thumbnail

RxSource optimizes clinical labeling process with PRISYM 360 cloud-based solution

pharmaphorum

For PRISYM ID client RxSource , a Global Clinical Trial Supplies Specialist, it means being ready to partner with sponsor companies to get everything set up for a clinical trial within a week, including packaging and labeling. To find out more about the webinar and to register, visit [link] .

article thumbnail

European Pharmacopoeia Goes Digital

PharmTech

EDQM will host a two-part webinar to present the benefits of the new platform. Information on how to register for the free webinars can be found on EDQM’s website. Thakar ; Varanya Chaiyaperm June 23rd 2025 Article Bulk drug calculations for different types of active moieties and drugs require different calculations and labeling.

Dosage 59